FBIOP.PFD (Fortress Biotech) Total Stockholders Equity : $22.25 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Fortress Biotech Total Stockholders Equity?

Fortress Biotech's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $22.25 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Fortress Biotech's Book Value per Share for the quarter that ended in Mar. 2025 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Fortress Biotech's Debt-to-Equity for the quarter that ended in Mar. 2025 was 3.34.

Fortress Biotech Total Stockholders Equity Historical Data

The historical data trend for Fortress Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Total Stockholders Equity Chart

Fortress Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

100.34

108.67

41.72

22.54

22.74

Fortress Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															23.03	17.88	21.16	22.74	22.25

Fortress Biotech (NAS:FBIOP.PFD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Fortress Biotech's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(22.25	-	0.003)	/	0
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Fortress Biotech's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.034	+	70.202)	/	22.25
	=	3.34

Fortress Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortress Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (NAS:FBIOP.PFD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

FBIO:USA CNB0.PFD:Germany

Address

1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website

https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.